Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition
93% overall response and 76% complete response rates with median progression-free survival…
TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm…
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET | Source: Fulcrum Therapeutics, Inc. ― Clear…
Yidan Prize Foundation connects global insights and local expertise at annual flagship Summit
500 changemakers from over 50 countries stand in solidarity with Hong Kong…
Unisys Opens Registration for Its 17th Annual Unisys Innovation Program
Engineering students are empowered to innovate with technologies such as artificial intelligence…
NYSE Content Advisory: Pre-Market Update + NYSE Hosts 102nd Annual Tree Lighting
NEW YORK, Dec. 4, 2025 /PRNewswire/ -- The New York Stock Exchange…
Menarini Group Announces New Data on ELZONRIS (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
Data spans five abstracts including two oral presentations with important findings for…
DXS INTERNATIONAL PLC (AQSE: DXSP): Notice of 2025 Annual General Meeting
November 24, 2025 02:00 ET | Source: DXS International PLC Monday 24…
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citis 2025 Global Healthcare Conference in December
November 21, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL…
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference
November 21, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, Nov.…
